ASX - By Stock
|
ASN |
Re:
Ann: Additional High Grade Critical Mineral Prospects at Ajana
|
|
HungrySponge84
|
24 |
9.2K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
24
|
9.2K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
HungrySponge84
|
901 |
283K |
0 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
901
|
283K
|
0
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Approval from State of Utah for Brine Extraction -GreenRiver
|
|
HungrySponge84
|
60 |
21K |
6 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
60
|
21K
|
6
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Approval from State of Utah for Brine Extraction -GreenRiver
|
|
HungrySponge84
|
60 |
21K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
60
|
21K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Binding Offtake Term Sheet with LG Energy Solution
|
|
HungrySponge84
|
289 |
95K |
33 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
289
|
95K
|
33
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Binding Offtake Term Sheet with LG Energy Solution
|
|
HungrySponge84
|
289 |
95K |
8 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
289
|
95K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
HungrySponge84
|
380 |
128K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
128K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
HungrySponge84
|
380 |
128K |
9 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
128K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
HungrySponge84
|
541 |
116K |
3 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
541
|
116K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
HungrySponge84
|
17K |
6.7M |
1 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
HungrySponge84
|
574 |
195K |
4 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
574
|
195K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
HungrySponge84
|
574 |
195K |
12 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
195K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
HungrySponge84
|
623 |
270K |
3 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
623
|
270K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Insider bullish on MSB prior fda approval
|
|
HungrySponge84
|
164 |
57K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
164
|
57K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
HungrySponge84
|
1.0K |
399K |
9 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
HungrySponge84
|
1.0K |
399K |
2 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
HungrySponge84
|
1.0K |
399K |
10 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
HungrySponge84
|
1.3K |
553K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
553K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
If the announcement does not have 'Approved' in the title, The End.
|
|
HungrySponge84
|
35 |
18K |
21 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
35
|
18K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
HungrySponge84
|
1.3K |
553K |
4 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
553K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
HungrySponge84
|
1.3K |
553K |
6 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
553K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
HungrySponge84
|
3.4K |
1.2M |
21 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
HungrySponge84
|
3.4K |
1.2M |
32 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
HungrySponge84
|
3.4K |
1.2M |
3 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
HungrySponge84
|
3.4K |
1.2M |
11 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
HungrySponge84
|
3.4K |
1.2M |
7 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
HungrySponge84
|
3.4K |
1.2M |
8 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
HungrySponge84
|
74 |
28K |
1 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
HungrySponge84
|
74 |
28K |
3 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Any data available regarding BLA resubmission acceptance rate?
|
|
HungrySponge84
|
3 |
1.7K |
7 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
3
|
1.7K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
HungrySponge84
|
355 |
96K |
3 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
355
|
96K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
HungrySponge84
|
576 |
205K |
3 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
205K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
6 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
32 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
5 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
31 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
15 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
9 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
HungrySponge84
|
321 |
103K |
29 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
321
|
103K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
|
|
HungrySponge84
|
299 |
104K |
27 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
299
|
104K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ruxolitinib Study for aGVHD in under 12s recruiting
|
|
HungrySponge84
|
47 |
10K |
2 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
47
|
10K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
HungrySponge84
|
34 |
14K |
1 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
34
|
14K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
HungrySponge84
|
9.7K |
2.9M |
1 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
9.7K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2021.... Year of the boom ?
|
|
HungrySponge84
|
346 |
109K |
1 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
346
|
109K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
HungrySponge84
|
17K |
6.7M |
1 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
HungrySponge84
|
213 |
58K |
2 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
213
|
58K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
HungrySponge84
|
505 |
160K |
4 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
505
|
160K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
HungrySponge84
|
144 |
56K |
12 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
144
|
56K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
HungrySponge84
|
317 |
73K |
6 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
317
|
73K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
HungrySponge84
|
317 |
73K |
7 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
317
|
73K
|
7
|
|